Institutional members access full text with Ovid®

1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced Pulmonary Fibrosis.

Selker, Robert G. M.D.; Jacobs, Samuel A. M.D.; Moore, Pearl B. M.N.; Wald, Michael M.D.; Fisher, Edwin R.; Cohen, Manfred M.D. M.D.; Bellot, Peter M.D.
Neurosurgery: December 1980
Clinical and scientific communications: PDF Only

: Clinical data are presented on 14 patients undergoing BCNU therapy for a primary intracranial glioma (11 biopsied, 3 suspected) in whom pulmonary fibrosis developed as a consequence of the therapy. Pulmonary diffusion abnormalities, dry hacking cough, and chest x-ray changes herald the onset of the process. Microscopic evaluation of lung specimens revealed a wide spectrum of change including hyaline membrane formation, alveolar septal thickening, interstitial fibrosis, and granuloma formation. It is concluded that BCNU causes pulmonary fibrosis that is primarily but not necessarily doserelated and may not be reversible. (Neurosurgery, 7: 560-565, 1980)

Copyright (C) by the Congress of Neurological Surgeons